United Therapeutics starts litigation with FDA for allowing Liquidia's drug application

In this article:

Feb 21 (Reuters) - United Therapeutics said on Wednesday it has commenced litigation with the U.S. FDA for allowing an application for a drug by Liquidia Corp to treat a type of blood vessel disorder. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)

Advertisement